newsfilter
← Latest News
Business Wire·

BBNX INVESTOR NOTICE: Faruqi & Faruqi, LLP Launches Investigation into Beta Bionics

  • Faruqi & Faruqi, LLP is investigating potential securities claims against Beta Bionics, Inc. (NASDAQ: BBNX).
  • On January 9, 2026, Beta Bionics shares declined sharply following the disclosure of preliminary fourth-quarter 2025 performance metrics that missed market expectations.
  • The stock dropped approximately $11.85, or 37.04%, to close at $20.14 after the company reported lower-than-anticipated new patient starts for its iLet automated insulin delivery system.
  • Securities litigation partner James (Josh) Wilson encourages investors who suffered significant losses to contact him directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
  • The firm, established in 1995 with offices in New York, Pennsylvania, California, & Georgia, has recovered hundreds of millions of dollars for investors.
  • Additional information regarding the investigation is available at www.faruqilaw.com/BBNX.